One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Glucosamine amino acids and derivatives other active pharmaceutical ingredients
Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients Product Name:Glucosamine amino acids and derivatives other active pharmaceutical ingredients CAS No.:7512-17-6 Standard:USP, EP Price(USD):0.00 Company:LAIYANG CHONDROPHARM BIOCHEMICAL CO LTD
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 10 TONS
Packaging Information: packaging : Length x Width x Height shipping_port :
Sample Provided: yes
Payment Terms: L/C, T/T, D/P
Glucosamine is commonly known as amino sugars, whose full name is n-amino-n-deoxy-Hexanal sugar. It is a compound that the glucose's an amino is substituted by a hydroxyl. It is an important nutrient to formate human cartilage cells. It can also be extracted from natural chitin and it is one of the main component of chondroitin sulfate.Glucosamine is freely soluble in water and insoluble in organic solvent such as ethanol, acetone, dioxane and so on.Glucosamine is an important prerequisite of the synthesis of Bifidobacterium factor; in the biological body it has many important physiological functions. In the clinical it is treatment of rheumatic and rheumatoid arthritis drug; it can be used as antioxidants in food and infant food additives, sweeteners of diabetic patients.Grade: Edible / Medicine.Storage: Preserved in tight container.Transmittance: >90%;Specific Optical Rotation: +38.9o - 42.9o;PH: 6.0 - 7.5;Loss on Drying: NMT 0.5%;Residue on Ignition: NMT 0.1%;
Eight years of qualification
Audited Supplier
Pharma Sources Insight January 2025
